Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cerus Corp.

Latest From Cerus Corp.

Pathogen-Reduction Tech Gets Some Focus At FDA Panel Meeting, But Not Enough, Cerus Says

While a panel of US FDA experts agreed that pathogen reduction technology is a promising strategy for reducing blood platelet contaminations, they raised concerns about the cost of implementing the technology. The maker of the technology, Cerus, says the panel was under-briefed and distracted.

Advisory Committees FDA

House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays

Emergency funding to battle the summer's mosquito-borne Zika threat is trapped in a military/VA spending bill. Conferees must find a compromise between the House's $622m bid and the Senate's $1.1b offer in the thin stretch of time when both chambers will be session before they adjourn on July 15. In the interim, FDA has authorized more Zika tests.

Medical Device Clinical Trials

News Briefs: Updates From Around The Industry

Device industry news on Dec. 2 includes an IDE approval to study a super-small neurostimulator to treat face pain; distribution agreements in diabetes and blood processing; a product approval; and new legislation focused on telemedicine.

Medical Device Strategy

Medical Device Deals Update, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Infection Control-Sterilization
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cerus Corp.
  • Senior Management
  • William M Greenman, Pres. & CEO
    Kevin D Green, VP, Fin. & CFO
    Laurence M Corash, MD, CSO
    Richard J Benjamin, PhD, CMO
  • Contact Info
  • Cerus Corp.
    Phone: (925) 288-6000
    2550 Stanwell Dr.
    Concord, CA 94520